Responding to Increasing Demand for Automation Equipment and Medical Instruments
First written in FY2018-Q1. 18 of 31 entries say "Advanced", first in FY2018. Latest entry: FY2026.
The whole theme swung hardest in 2020: 6 of 20 companies on the "Worse" side.
12 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Automatic equipment remained solid, while increased demand for medical equipment resulted in higher sales and profit compared with the previous fiscal year.」
Firm demand for automatic equipment and increased demand for medical equipment resulted in a 9.5% increase in segment sales and a 17.8% increase in segment profit in the machinery and equipment segment. - FY2025AdvancedAnnual report
「Demand for both automated equipment and medical devices exceeded plan and remained firm, resulting in higher revenue and profit year on year. As a result, revenue was ¥6,439 million, up 12.4% year on year, and segment profit was ¥741 million, up 10.3%.」
Demand for automated equipment and medical devices exceeded plan, resulting in a 12.4% increase in revenue and a 10.3% increase in segment profit in the Machinery and Equipment segment. - FY2025-H1AdvancedAnnual report
「Demand for both automated equipment and medical devices exceeded plan and remained firm, resulting in higher revenue and profit year on year. As a result, revenue was ¥3,122 million, up 14.9% year on year, and segment profit was ¥366 million, up 18.8%.」
From the previous weakness caused by cautious automotive-related capital spending, demand for both automated equipment and medical devices exceeded plan in the current interim period, resulting in a 14.9% increase in revenue and an 18.8% increase in segment profit. - FY2024AdvancedAnnual report
「The company focused its sales on various automated equipment and medical devices. Medical devices remained firm, while automotive-related customers remained cautious on capital spending; however, efficiency improvements at the automated equipment business resulted in higher segment profit. As a result, revenue was ¥5,726 million, down 0.3% year on year, and segment profit was ¥672 million, up 23.5%.」
Despite cautious capital spending by automotive-related customers, efficiency improvements, together with firm medical devices, resulted in a 23.5% year-on-year increase in segment profit. - FY2024-Q3RestatedAnnual report
「The company focused its sales on various automated equipment and medical devices. Revenue from automated equipment fell below the year-earlier level as automotive-related capital spending remained cautious, but profit exceeded the year-earlier level because production efficiency was maintained and medical devices performed firmly. As a result, revenue was ¥4,089 million, down 4.4% year on year, and segment profit was ¥423 million, up 10.6%.」
The pattern continued of lower revenue from automated equipment due to cautious automotive-related capital spending, offset by higher profit supported by firm medical devices and maintained production efficiency. - FY2024-Q2AdvancedAnnual report
「The company focused its sales on various automated equipment and medical devices. Revenue from automated equipment fell below the year-earlier level as automotive-related capital spending remained cautious, but profit exceeded the year-earlier level because production efficiency was maintained and medical devices performed firmly. As a result, revenue was ¥2,717 million, down 3.8% year on year, and segment profit was ¥309 million, up 27.8%.」
Automated equipment revenue declined due to cautious automotive-related capital spending, while segment profit increased 27.8% year on year as production efficiency was maintained and medical devices remained firm. - FY2024-Q1Automated equipment weak on cautious capital spending; medical assembly firmAnnual report
「In the Machinery and Equipment segment, automated equipment was weak as automotive-related capital spending remained cautious, while medical assembly performed firmly.」
Automated equipment was weak due to cautious automotive-related capital spending, while medical assembly remained firm. - FY2023RestatedAnnual report
「Medical devices performed firmly, but production plans for automated equipment were delayed as there was no sign of improvement in shortages of purchased materials. As a result, revenue was ¥5,743 million, down 2.0% year on year, and segment profit was ¥544 million, down 10.8%.」
The company continued to report firm medical devices, but also reported full-year delays to automated equipment production plans and lower revenue and profit due to shortages of purchased materials. - FY2023-Q3RestatedAnnual report
「Medical devices performed firmly, but production plans for various automated equipment were delayed due to shortages of purchased materials, resulting in lower revenue and profit.」
Delays to production plans for automated equipment due to shortages of purchased materials continue. Medical devices are reported to be firm. - FY2023-Q1WorsenedAnnual report
「Medical devices performed firmly, but production plans for various automated equipment were delayed due to shortages of purchased materials, resulting in lower revenue and profit.」
As shortages of purchased materials persisted, production plans for various automated equipment were actually delayed, resulting in lower revenue and profit. Medical devices were reported to be firm. - FY2022-Q3WorsenedAnnual report
「Orders for automotive equipment remained firm, but production plans were delayed due to the prolonged impact of shortages of purchased materials. Profit from medical devices fell below the year-earlier level because production volumes for some products declined.」
Although orders for automotive equipment were firm, prolonged shortages of purchased materials actually delayed production plans, while profit from medical devices declined due to lower production volumes for some products. - FY2022-Q2Profit declined due to tight supplies of purchased materials and lower medical device productionAnnual report
「Orders for automotive equipment remained firm, but prolonged shortages of purchased materials raised concerns about their impact on production plans. Profit from medical devices fell below the year-earlier level because production volumes for some products declined.」
Orders for automotive equipment were firm, but the company was concerned about the impact of prolonged shortages of purchased materials on production plans. Profit from medical devices declined due to lower production volumes for some products. - FY2022-Q1Profit declined as momentum in medical devices slowedAnnual report
「Automotive-related equipment and other products performed firmly, but momentum in medical devices slowed, resulting in lower profit.」
Automotive-related equipment and other products were firm, but momentum in medical devices slowed, resulting in lower profit in the Machinery and Equipment segment. - FY2021AdvancedAnnual report
「Various automated equipment, including automotive-related equipment, continued to perform well, and demand for medical devices remained firm. As a result, revenue was ¥6,554 million, up 19.6% year on year, and segment profit was ¥745 million, up 11.6%.」
Against a backdrop of strong performance by automotive-related equipment and firm demand for medical devices, revenue in the Machinery and Equipment segment increased 19.6% and segment profit increased 11.6%. - FY2021-Q3AdvancedAnnual report
「The company focused its sales on various automated equipment and medical devices. Automotive-related equipment and other automated equipment performed firmly, while medical devices maintained a stable trend. As a result, revenue was ¥5,019 million, up 23.1% year on year, and segment profit was ¥607 million, up 24.6%.」
Against a backdrop of firm automotive-related equipment and other products and stable medical devices, revenue in the Machinery and Equipment segment increased 23.1% and segment profit increased 24.6%. - FY2021-Q2AdvancedAnnual report
「The company focused its sales on various automated equipment and medical devices. Automotive-related equipment and other automated equipment performed firmly, while medical devices maintained a stable trend. As a result, revenue was ¥3,344 million, up 23.3% year on year, and segment profit was ¥423 million, up 36.8%.」
Against a backdrop of firm automotive-related equipment and other products and stable medical devices, revenue in the Machinery and Equipment segment increased 23.3% year on year and segment profit increased 36.8%. - FY2021-Q1AdvancedAnnual report
「Medical and automotive equipment performed well, while medical devices also remained firm. As a result, revenue was ¥1,494 million, up 13.0% year on year, and segment profit was ¥211 million, up 32.6%.」
Against a backdrop of strong performance by medical and automotive equipment and firm medical devices, revenue in the Machinery and Equipment segment increased 13.0% year on year and segment profit increased 32.6%. - FY2020AdvancedAnnual report
「Semiconductor-related and automotive equipment performed firmly, while orders for medical devices exceeded plan against a backdrop of strong market demand. As a result, revenue was ¥5,482 million, up 12.0% year on year, and segment profit was ¥668 million, up 1.3%.」
Against a backdrop of demand for automated equipment and medical devices, revenue in the Machinery and Equipment segment increased 12.0% year on year and profit increased 1.3%. - FY2020-Q3AdvancedAnnual report
「Demand is also expected to continue expanding steadily. In future business development, improving product precision and production efficiency through the introduction of automation technology and IoT will be essential. To allocate our management resources more efficiently and strengthen our business foundation, we established a subsidiary specializing in the medical device business. (5) Size: Capital ¥80 million (6) Date of establishment: 13 April 2020 (7) Equity ownership: 株式会社鈴木 100%」
Anticipating expanding demand for the medical device business, the company established a wholly owned subsidiary with capital of ¥80 million on 13 April 2020 to improve precision and production efficiency through automation technology and IoT. - FY2020-Q2RestatedAnnual report
「Semiconductor-related and automotive equipment performed firmly, while orders for medical devices exceeded plan against a backdrop of strong market demand. However, profit declined due to higher depreciation and labor costs.」
Although semiconductor- and automotive-related equipment remained firm and orders for medical devices continued to exceed plan, profit in the Machinery and Equipment segment declined due to higher depreciation and labor costs. - FY2020-Q1AdvancedAnnual report
「Semiconductor-related and automotive equipment performed firmly, while orders for medical devices exceeded plan against a backdrop of strong market demand. As a result, revenue was ¥1,322 million, up 17.6% year on year, and segment profit was ¥159 million, up 10.0%.」
Semiconductor- and automotive-related equipment performed firmly, while orders for medical devices exceeded plan. Revenue in the Machinery and Equipment segment increased 17.6% and segment profit increased 10.0%. - FY2019AdvancedAnnual report
「In the Machinery and Equipment business, the company made capital expenditures of ¥809.699 million, mainly for new factory construction to increase production of medical devices.」
The company is proceeding with new factory construction to increase production of medical devices and made ¥809.699 million in capital expenditures in the Machinery and Equipment business. - FY2019-Q3RestatedAnnual report
「Automotive and semiconductor-related equipment and other automated equipment performed firmly, while orders for medical devices exceeded plan against a backdrop of strong market demand.」
The company continues to report firm performance by automotive and semiconductor-related equipment and orders for medical devices above plan. - FY2019-Q2AdvancedAnnual report
「Automotive and semiconductor-related equipment performed firmly, and orders for medical devices exceeded plan against a backdrop of strong market demand.」
Automotive and semiconductor-related equipment performed firmly, while orders for medical devices exceeded plan. - FY2019-Q1AdvancedAnnual report
「Demand for automotive equipment increased, while medical devices also performed firmly against a backdrop of strong market demand. As a result, revenue and profit in this segment increased year on year. Revenue was ¥1,125 million, up 17.3% year on year, and segment profit was ¥144 million, up 27.4%.」
Against a backdrop of demand for automotive equipment and medical devices, revenue in the Machinery and Equipment segment increased 17.3% year on year and profit increased 27.4%. - FY2018AdvancedAnnual report
「To strengthen our business platform and expand the business, we will continue strategic investment to establish a production-increase structure for medical devices, which we view as a future growth area, and to execute production plans for components such as automotive batteries. We will also focus on research and development.」
The company continues to build capacity to increase production of medical devices and is turning production plans for components such as automotive batteries into a new growth area. - FY2018-Q3RestatedAnnual report
「Various automated equipment increased in line with customers' expansion plans for both automotive and medical equipment, while medical devices also performed firmly against a backdrop of strong market demand. As a result, revenue and profit in this segment increased year on year.」
Revenue and profit in the Machinery and Equipment segment increased year on year against a backdrop of expansion demand for automotive and medical equipment and strong demand for medical devices. - FY2018-Q2RestatedAnnual report
「Various automated equipment increased in line with customers' expansion plans for both automotive and medical equipment. The company is also systematically increasing production of medical devices to meet growing market demand.」
The company continues to systematically increase production in response to higher demand for automotive and medical equipment and medical devices. - FY2018-Q1First statedAnnual report
「Various automated equipment increased as automotive and medical equipment performed firmly and demand for related special-purpose machines and materials also rose on the strength of the assembly and semiconductor industries. Medical devices also grew as production was increased to meet higher demand, resulting in year-on-year increases in revenue and profit in this segment.」
In response to increased demand related to automotive, medical, assembly and semiconductor applications, the company is increasing sales of special-purpose machines and materials and ramping up production of medical devices.